Related Experiment Video
Updated: Mar 29, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.7K
[Inhaled in chronic obstructive pulmonary disease therapy update].
A Viejo-Casas1, C Bonnardeaux-Chadburn2, L Ginel-Mendoza3
1Centro de Salud Alto Pas, Servicio Cántabro de Salud, Ontaneda, Cantabria, España; Grupo de Trabajo de Respiratorio de SEMERGEN, España.
Semergen
|December 15, 2015
Summary
Recent advances in chronic obstructive pulmonary disease (COPD) treatment offer new inhaled medications and devices. This review updates knowledge on COPD therapies, aiding clinicians in selecting the most effective inhaler for patients.
Area of Science:
- Pulmonology
- Pharmacology
- Medical Devices
Background:
- Chronic obstructive pulmonary disease (COPD) understanding has advanced significantly.
- Drug development has expanded therapeutic options for COPD.
- Inhaled drug delivery targets the bronchial tree directly for COPD treatment.
Purpose of the Study:
- To provide an updated review of inhaled medications for COPD.
- To analyze the advantages and disadvantages of various inhaler devices.
- To guide the selection of appropriate inhaler devices for COPD management.
Main Methods:
- Review of current literature on COPD inhaled therapies.
- Analysis of available inhaler device types.
- Comparative assessment of device advantages and disadvantages.
Main Results:
- New inhaled molecules and devices have recently emerged for COPD treatment.
- A variety of inhaler devices are available, each with unique characteristics.
- Understanding device-specific benefits and drawbacks is crucial for optimal drug delivery.
Conclusions:
- An update on inhaled COPD therapies is necessary due to recent innovations.
- Informed selection of inhaler devices is critical for effective COPD management.
- This review aims to reduce uncertainty in choosing the right inhaler for COPD patients.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:23Inhaled Medications
988
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
988
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
01:24Chronic Obstructive Pulmonary Disease
3.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.1K
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
739
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
739